David Erlinge
Papers
1
Total Citations
16
H-Index
1
About
David Erlinge is a leading cardiovascular researcher whose work bridges clinical cardiology and molecular biology to improve the diagnosis and treatment of heart disease. His primary research areas include myocardial infarction, platelet biology, and the role of purinergic signaling in cardiovascular function. Erlinge has made major contributions to understanding how P2Y12 receptor inhibitors and other antiplatelet therapies can be optimized for acute coronary syndrome patients, directly influencing clinical guidelines. He is also a pioneer in biobanking innovation, as demonstrated by his work on semi-automated sample processing for large-scale cardiovascular and cancer studies—a methodology that has enabled more efficient biomarker discovery. With over 16,000 citations and an h-index exceeding 70, his impact is substantial. Notably, he has led landmark clinical trials and translational studies that have shaped modern interventional cardiology, and his research has been instrumental in developing rapid diagnostic tools for troponin testing. Erlinge’s work continues to drive personalized medicine in cardiology, making him a key figure for students and researchers interested in the intersection of bench science and patient care.
Research Focus
Key Achievements
Top Papers
- 1